Telmisartan 40mg Tablets (Telmisartan)

Adult dose

1. Essential Hypertension Telmisartan should be administered orally once daily at a dose of 40 mg with water, with or without food. In some cases, a dose of 20 mg once daily may be effective. If necessary, the dose can be increased up to 80 mg once daily. The maximum blood pressure-lowering effect will be observed 4 to 8 weeks after dose escalation. 2. Reduction of Cardiovascular Disease Risk 1

This medication can cause serious harm to the fetus if taken during pregnancy; therefore, it must be discontinued immediately if pregnancy is confirmed. Patients who have an allergic reaction to this drug, pregnant women, patients with severe liver dysfunction or biliary excretion disorders, patients with hereditary angioedema, and patients with severe renal impairment should not take this medication. Elderly patients, patients with high serum potassium levels, mild to moderate liver dysfunction, patients with cardiac valve disease, and patients with ischemic heart disease should use this drug cautiously. Since this medication lowers blood pressure, symptoms such as hypotension, dizziness, or fainting may occur; therefore, careful monitoring of symptoms is necessary during use. Serum potassium levels may increase, so serum potassium concentrations should be checked regularly, and if symptoms of hyperkalemia occur, medical attention should be sought immediately. Patients with reduced kidney function should undergo frequent kidney function tests before and after taking this medication, and if abnormal signs appear, the medication may need to be discontinued. Care should be taken when using this drug in combination with other antihypertensives as it may enhance blood pressure-lowering effects. Interactions may occur when taken with certain medications; therefore, it is essential to consult a doctor or pharmacist if taking other medications. Caution is warranted when driving or operating machinery due to the risk of dizziness and fainting. This medication contains sorbitol, so patients with fructose intolerance should avoid it. Pregnant or breastfeeding women should not take this medication, and if it must be taken, breastfeeding should be discontinued. Overdose may result in hypotension, dizziness, acute renal failure, and prompt medical treatment is necessary. Children and adolescents under 18 years of age are not recommended to use this medication as safety and efficacy have not been established. This medication should be stored in a tightly closed container away from moisture and light, and it is preferable not to transfer it to another container.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucous membranes, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, significant reduction in urine output.

Mild side effects

• Upper respiratory infection
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia
• hypoglycemia
• hyponatremia

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This helps to preserve the medication's efficacy and prevent deterioration.

Appearance

White or nearly white, biconvex, round tablets

Package unit

10 tablets/blister X 3